Cannabis and cannabinoid research

Cannabis Cannabinoid Res · ISSN (e) 2378-8763 · 4 papers in corpus · 2017-2024

Year distribution

Study types

  • other 2
  • article 1
  • review 1

Condition tags

  • endometriosis 4
  • mesh:D004715 3
article 2024
doi:10.1089/can.2024.0081 ·PMID:39286880

Introduction: Anandamide (AEA) and 2-arachidonoylglycerol are endogenous agonists of the cannabinoid receptors and regulate and control many cellular functions. Their activities are governed by enzymes and proteins that regulate their synth…

other 2022
doi:10.1089/can.2021.0116 ·PMID:34978929

Introduction: Endometriosis is a difficult to manage condition associated with a significant disease burden. High levels of illicit cannabis use for therapeutic purposes have been previously reported by endometriosis patients in Australia a…

other 2022
doi:10.1089/can.2021.0162 ·PMID:35089093

Introduction: Endometriosis affects 1 in 10 women worldwide, with most experiencing difficulties achieving adequate symptom control. These difficulties have been compounded by the onset of the COVID-19 pandemic due to worldwide shifts in he…

review 2017
doi:10.1089/can.2016.0035 ·PMID:28861506

Introduction: Patients with endometriosis often suffer from diffuse and poorly localized severe pain. The current pain management strategies include medical and hormonal therapy, as well as surgery. Medical management of pain is often insuf…